CSF levels of receptor-active endorphins in schizophrenic patients: Correlations with symptomalogy and monoamine metabolites

[1]  L. Terenius,et al.  Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat , 1986, Brain Research.

[2]  L. Terenius,et al.  Enkephalin-containing polypeptides in human cerebrospinal fluid , 1986, Brain Research.

[3]  L. Terenius,et al.  Hallucinations in patients with major depression. Interactions between CSF monoaminergic and endorphinergic indices. , 1985, Journal of affective disorders.

[4]  R. Quirion,et al.  Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra , 1985, Brain Research.

[5]  L. Terenius,et al.  Characterization of electrophoretically separable endorphins in human CSF , 1983, Brain Research.

[6]  T. Hökfelt,et al.  Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway. , 1982, European journal of pharmacology.

[7]  D. Naber,et al.  Clinical studies of the endogenous opioid system. , 1982, Biological psychiatry.

[8]  L. Terenius,et al.  Endorphins in human cerebrospinal fluid. , 1982, Life sciences.

[9]  H. Akil,et al.  The effects of naloxone in chronic schizophrenia. , 1981, The American journal of psychiatry.

[10]  L. Terenius,et al.  Cerebrospinal fluid endorphins in schizophrenia , 1980, Acta psychiatrica Scandinavica.

[11]  W. Fratta,et al.  Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum , 1979, Brain Research.

[12]  H. Akil,et al.  Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects. , 1978, Science.

[13]  W. Fratta,et al.  Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs. , 1978, The Journal of pharmacology and experimental therapeutics.

[14]  M. Åsberg,et al.  A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE , 1978, Acta psychiatrica Scandinavica. Supplementum.

[15]  L. Terenius,et al.  Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic states , 1978, Acta psychiatrica Scandinavica.

[16]  O. McCabe,et al.  The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride. , 1977, The American journal of psychiatry.

[17]  H. Emrich,et al.  Indication of an Antipsychotic Action of the Opiate Antagonist Naloxone , 1977, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

[18]  D. Segal,et al.  Lack of effect on naloxone on schizophrenic symptoms. , 1977, The American journal of psychiatry.

[19]  J. Kleinman,et al.  Intravenous naloxone administration in schizophrenia and affective illness. , 1977, Science.

[20]  J. Volavka,et al.  Naloxone in chronic schizophrenia. , 1977, Science.

[21]  L. Terenius,et al.  Morphine-like ligand for opiate receptors in human CSF. , 1975, Life sciences.

[22]  D. Jasinski,et al.  Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone , 1968, Clinical pharmacology and therapeutics.

[23]  L. Lasagna,et al.  The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. , 1954, The Journal of pharmacology and experimental therapeutics.